Skip to main content
. 2016 Jan 25;46(6):1249–1263. doi: 10.1017/S0033291715002780

Table 1.

Sample characteristics and statistical differences between the symptomatic, remitted, non-clinical and control groups

Characteristics C-S (n = 18) C-R (n = 16) NC (n = 16) Controls (n = 21) Significance tests
Gender, n Male Female 13
5
8
8
5
11
7
14
χ23 = 7.826, p = 0.050 (V = 0.33) C-S: male > female
Mean age, years (s.d.) 42.56 (12.03) 43.75 (11.95) 52.5 (9.25) 30.05 (10.32) F3,67 = 13.35, p < 0.001 (ηp2 = 0.37)f***, i**
Ethnicity, n Whites 7 11 14 15 χ26 = 12.76, p = 0.047 (V = 0.30)
Non-whites 11 5 2 6 C-S: non-white > white
Employment, n Employed/in education 4 7 15 17 χ23 = 23.11, p < 0.001 (V = 0.57) NC and controls: employed > unemployed;
Not employed 14 9 1 4 C-S: unemployed > employed
Mean time in education, years (s.d.)a 15.12 (3.76) 15.07 (3.73) 22.5 (8.00) 18.95 (7.05) F3,64 = 5.46, p = 0.002 (ηp2 = 0.20)d**, e**
Highest level of education, n University education 7 5 11 15 χ23 = 17.31, p = 0.001 (V = 0.49) NC: university > no university
No university education 11 11 5 6
Mean WTAR (s.d.) Predicted full-scale IQ 102.33 (10.19) 103.31 (8.25) 109.31 (3.50) 111 (4.74) F3,67 = 6.69, p = 0.001 (ηp2 = 0.23)d*, g**, h*
Religious affiliation, n Traditional 15 7 7 5 χ26 = 18.25, p = 0.004, (V = 0.36)
Other/spiritual 1 2 2 1 C-S: traditional > no affiliation
None 2 7 7 16
Mean DASS-21 (s.d.) Depression 6.56 (4.78) 7.25 (6.56) 0.69 (1.08) 1.57 (1.63) F3,67 = 11.84, p < 0.001 (ηp2 = 0.35)i**, j***, k***, l***
Anxiety 5.72 (5.30) 6.75 (5.94) 0.94 (1.18) 0.90 (1.37) F3,67 = 10.57, p < 0.001 (ηp2 = 0.32)i**, j**, k***, l**
Stress 7.67 (6.16) 9.31 (6.03) 2.69 (2.09) 3.14 (3.51) F3,67 = 8.32, p < 0.001 (ηp2 = 0.27)i*, j*, k**, l**
Parental occupation, n Professional/intermediate 13 10 12 16 χ23 = 2.17, p = 0.54 (V = 0.18)
Other 5 6 4 4
Missing value 0 0 0 1
Children, n Yes 3 6 11 2 χ23 = 17.24, p = 0.001 (V = 0.49)
No 15 10 5 19 NC: children > no children
Diagnosis by ICD-10 Schizophrenia = 14 (78%) Schizo-affective = 2 (11%) Psychosis NOS = 0 F30–F39 = 2 (11%) Schizophrenia = 6 (37.5%) Schizo-affective = 1 (6.25%) Psychosis NOS = 1 (6.25%)
F30–F39 = 8 (50%)
Schizophrenia: C-S > C-R F30–F39: C-R > C-S
Antipsychotic medication and dosages Medicated = 17 (94.4%) None = 1 (5.6%) Typical = 5.6% Atypical = 66.7% Clozapine = 16.7% More than 1 = 11.1% Median = 50% maximum daily
recommended dose (range = 17–100%)b
Medicated = 10 (62.5%) None = 6 (37.5%) Typical = 0%
Atypical = 37.5% Clozapine = 12.5% More than 1 = 0% Median = 39% maximum daily recommended dose (range = 5– 100%)c
χ21 = 3.70, p = 0.054 (V = 0.33) On medication: C-S > C-R
Mean number of admissions [median] (range) 5.59 [4] (0–17) 2.69 [2] (0–10) U = 51.5, p = 0.012 (d = 0.64)
Mean time since onset, years (s.d.) 20.47 (13.15) 19.20 (14.16) 38.07 (15.44) F2,43 = 8.02, p = 0.001 (ηp2 = 0.27)d**, e**

C-S, Symptomatic, C-R, remitted, NC, non-clinical; s.d., standard deviation; WTAR, Wechsler Test of Adult Reading; IQ, intelligence quotient; DASS-21, 21-item Depression Anxiety and Stress Scales; ICD, International Classification of Diseases; NOS, not otherwise specified.

a

One value was missing for C-S, and two for C-R.

b

Six participants had missing data for dosage.

c

One participant had missing data for dosage.

d

NC v. C-S.

e

NC v. C-R.

f

NC v. controls.

g

Controls v. C-S.

h

Controls v. C-R.

i

C-S v. controls.

j

C-S v. NC.

k

C-R v. controls.

l

C-R v. NC.

*

p < 0.05, ** p < 0.01, *** p < 0.001 (Tukey's least significant difference test).